In LRRK2 PD specifically, SAA sensitivity is notably reduced (around 67.5%), and in normosmic female carriers, it drops below 15%, suggesting a potential disconnect between clinical phenotype and α-synuclein pathology. Here, LRRK2 is linked to Parkinson disease.